rameters were measured before prescription of a low caloric diet adjusted to age, gender, physical activity and professional lifestyle. Implementation of aerobic exercise was performed as well. The average follow-up was 12Ϯ3 months. Stroke volume (SV), total vascular resistance (TVR) parameters were derived non-invasively by TNO® "modelflow" analysis applied to the Finapress arterial wave. Baroreceptor function (BR) was calculated by ␣-index, HF_RR (vagal tonus) and LF_SBP (sympathetic tonus) by FFT. During follow-up there were no changes on salt intake.
First evaluation Last evaluation
Weight ( Hypertension is common in patients with chronic renal failure (CRF), however the role of hypertension as a predictor of mortality in dialysis patients is controversial. The influence of hypertension before admission on dialysis and the mortality during hemodialysis was studied. Other potential risk factors such age, sex, renal disease, comorbidity, past history of atherosclerosis (heart, cerebral or peripheral arteries ischemic disease), electrocardiographyc left ventricular hypertrophy (LVH), X-ray vascular calcifications (VC) and serum albumin concentration were also taken into account. Patients and Methods. Two hundred and one patients, 124 (62%) males and 77 (38%) females(mean age: 51 years) were followed up for 78 months after starting dialysis. The patients were classified according to the blood pressure measurements obtained during the follow-up period of the renal disease, considering three groups: normotensive (NH), controlled hypertensive (c-HT) (blood pressure Ͻ 140/90), and uncontrolled hypertensive (uc-HT) (blood pressure Ͼ140/ 90). Kaplan-Meier analysis and Cox's Proportional Hazards Model were used for statistical analysis. Results. From the 201 patients, 184 were enrolled. The mean age was similar in all groups. The prevalence of NH, c-HT and un-HT was 27% (nϭ 49), 36% (nϭ66), and 37% (nϭ66) respectively. The prevalence of atherosclerosis was higher in the hypertensive group (NH 14% (nϭ6) vs c-HT 49% (nϭ 21) vs un-HT 37% (nϭ 16), pϭ0.046). Left ventricular hypertrophy was also higher in hypertensive patients (NH 13% (nϭ10) vs c-HT 48% (nϭ 37) vs un-HT 39% (nϭ 30), pϭ0.0005), as well as vascular calcifications (NH 18%(nϭ13) vs c-HT 39%(nϭ 28) vs un-HT 43% (nϭ 31), pϭ0.103). Survival rates at 1, 3, 5, and 10 years of the un-HT group were significantly worse (Log-Rank test, pϭ0.0066). Comorbidity (RR: 2.25 (1.43-3.54), pϭ0.0005) and uncontrolled hypertension (RR: 2.12 (1.22-3.70), pϭ0.0074) were independent predictors of mortality. In addition, the percentage of uncontrolled hypertensive patients during hemodialysis was significantly higher in the uncontrolled hypertensive group in predialysis regarding the controlled hypertensive and normotensive group in predialysis (30% (nϭ 21) vs 9% (nϭ 6) vs 4% (nϭ 2)). Conclusion.
Predialysis uncontrolled hypertension and comorbidity are independent predictors of mortality in hemodialysis patients. Uncontrolled hypertensive patients during predialysis are worse controlled during hemodialysis. In addition, these results suggest association between history of atherosclerosis and left ventricular hypertrophy with hypertension. Hypertension is common in patients with chronic renal failure (CRF) and although it has been related with higher cardiovascular mortality, this is controversial. The relationship between hypertension before introducing to the first treatment for end-stage renal disease, and mortality during kidney transplantation was studied. Other potential risk factors such age, sex, renal disease, comorbidity, past history of atherosclerosis (heart, cerebral or peripheral arteries ischemic disease), electrocardiographyc left ventricular hypertrophy (LVH), X-ray vascular calcifications (VC) and serum albumin concentration were also taken into account. Patients and Methods. Two hundred and forty-two patients, 157 (65%) males and 85 (35%) females (mean age: 35 Ϯ 13 years) were followed up for 78 Ϯ 57 months. The patients were classified according to the blood pressure measurements obtained during the follow-up period of the renal disease, considering three groups: normotensive (NH), controlled hypertensive (c-HT) (blood pressure Ͻ 140/90), and uncontrolled hypertensive (uc-HT) (blood pressure Ͼ140/90) patients. Kaplan-Meier analysis and Cox's Proportional Hazards Model were used for statistical analysis. Results. From the 242 patients, 230 were enrolled. Prevalence of NH, c-HT and un-HT was 28% (nϭ 66), 43% (nϭ99), and 29% (nϭ65) respectively. Left ventricular hypertrophy was higher in hypertensive patients (NH 10% (nϭ7) vs c-HT 43% (nϭ 29) vs un-HT 46% (nϭ 31), pϭ0.000), as well as X-ray vascular calcifications (NH 8% (nϭ 2) vs c-HT 52% (nϭ 12) vs un-HT 39% (nϭ 9), pϭ0.1157). Survival rates at 1, 3, 5, and 10 years of the un-HT group were significantly worse (Log-Rank test, pϭ0.0087). Uncontrolled hypertension (RR: 3.89 (1.44-10.5), pϭ0.007), past history of atherosclerosis (RR: 2.80 (1.12-6.98), pϭ0.025) and vascular calcifications (RR: 2.38 (1.07-5.25), pϭ0.029) were independent predictors of mortality. Serum albumin concentration showed a protecting effect (RR:0.5 (0.27-0.99), pϭ0.044). In addition, the percentage of uncontrolled hypertensive patients during kidney transplantation was significantly higher in the uncontrolled hypertensive group in predialysis regarding the controlled hypertensive and normotensive group (22% (nϭ 14) vs 4% (nϭ3) vs 6% (nϭ4)). Conclusion. Predialysis uncontrolled hypertension, past history of atherosclerosis, X-ray vascular calcifications and serum albumin concentration are independent predictors of mortality in kidney transplant patients. Uncontrolled hypertensive patients during predialysis are worse controlled during renal transplant.
